摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氨基-2-氯-4-硫苯甲酸 | 5855-78-7

中文名称
5-氨基-2-氯-4-硫苯甲酸
中文别名
5-氨基-2-氯-4-磺基苯甲酸
英文名称
Benzoic acid, 5-amino-2-chloro-4-sulfo-
英文别名
5-amino-2-chloro-4-sulfobenzoic acid
5-氨基-2-氯-4-硫苯甲酸化学式
CAS
5855-78-7
化学式
C7H6ClNO5S
mdl
——
分子量
251.64
InChiKey
JGSAMPZLJLDOKW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.810±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    126
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • [EN] INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS<br/>[FR] DÉRIVÉS D'INDOLE-3-GLYOXYLAMIDE DESTINÉS À ÊTRE UTILISÉS COMME MODULATEURS DES CANAUX CALCIQUES
    申请人:LECTUS THERAPEUTICS LTD
    公开号:WO2009133387A1
    公开(公告)日:2009-11-05
    Compounds of formula (I) are of use in treating a range of conditions, including pain.
    化合物的化学式(I)可用于治疗一系列疾病,包括疼痛。
  • [EN] CALCIUM ION CHANNEL MODULATORS & USES THEREOF<br/>[FR] MODULATEURS DES CANAUX IONIQUES CALCIQUES ET LEURS UTILISATIONS
    申请人:LECTUS THERAPEUTICS LTD
    公开号:WO2010035032A1
    公开(公告)日:2010-04-01
    Compounds of formula (I), wherein R1 is hydrogen, hydroxyl or aralkyl; R2 is an optionally substituted alkyl, aryl or heteroaryl (said substituents are selected from hydroxyl, alkoxyl, haloalkoxyl, aryl, heteroaryl, cycloalkyl, amino, monoalkylamino, dialkylamino, alkylsulphonyl, alkylsulphinyl, alkylsulphonylamino, acylamino, saturated or partially unsaturated heterocyclic groups and groups of formula COY); W is selected from oxygen, sulphur, groups of formula NR7, wherein R7 is hydrogen, alkyl, aryl or heteroaryl and groups of formula CR8R9, wherein R8 and R9 are hydrogen, alkyl, aryl or heteroaryl; and X is selected from nitrogen and groups of formula CR10, wherein R10 is hydrogen, alkyl, aryl, heteroaryl, halogen or haloalkyl, inhibit the interaction between Cavx channels and Cavβ proteins and are of use in the treatment and prevention of a number of diseases and conditions including pain and lower urinary tract disorders.
    式(I)中的化合物,其中R1是氢、羟基或芳基烷基;R2是可选择取代的烷基、芳基或杂环芳基(所述取代基选自羟基、烷氧基、卤代烷氧基、芳基、杂环芳基、环烷基、基、单烷基基、双烷基基、烷基磺酰基、烷基亚砜基、烷基磺酰基、酰基、饱和或部分不饱和的杂环族和式COY);W选自氧、、式NR7的基团,其中R7是氢、烷基、芳基或杂环芳基,以及式CR8R9的基团,其中R8和R9是氢、烷基、芳基或杂环芳基;X选自氮和式CR10的基团,其中R10是氢、烷基、芳基、杂环芳基、卤素或卤代烷基,能够抑制Cavx通道与Cavβ蛋白之间的相互作用,并可用于治疗和预防包括疼痛和下尿路障碍在内的多种疾病和症状。
  • PIGMENT DISPERSING AGENT, PIGMENT COMPOSITION, AND PIGMENT COLORING AGENT
    申请人:DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD.
    公开号:US20200377480A1
    公开(公告)日:2020-12-03
    The present invention provides a pigment dispersant: that is capable of remarkably ameliorating fluidity of a liquid product, such as an ink or a paint, which contains particles of a pigment, such as a black azo pigment, in a dispersed state; that can suppress aggregation of piment particles; that prevents occurrence of foreign substances; and that is capable of producing a colored article excellent in optical density. Provided is a pigment dispersant being a compound represented by the following formula (1). wherein R 1 and R 2 each independently represent a group obtained by eliminating one hydrogen atom from an amino group of an amine compound containing a basic nitrogen atom, and R 3 and R 4 each independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, or a hydroxy group.
    本发明提供了一种颜料分散剂:能够显著改善液体产品(如墨或油漆)的流动性,其中液体产品中包含颜料颗粒(如黑色偶氮颜料)处于分散状态;能够抑制颜料颗粒的聚集;防止异物的发生;并能够生产具有优异光密度的彩色制品。提供的颜料分散剂是由以下化学式(1)表示的化合物,其中R1和R2分别独立表示通过从含有碱性氮原子的胺化合物的基中消除一个氢原子而获得的基团,而R3和R4分别独立表示氢原子、卤素原子、烷基、烷氧基或羟基。
  • [EN] POLYMERIZABLE COMPOSITIONS<br/>[FR] COMPOSITIONS POLYMÉRISABLES
    申请人:BASF SE
    公开号:WO2010112410A1
    公开(公告)日:2010-10-07
    The invention relates to the use of triazenes of formula (I) wherein Q is a direct bond or a bivalent radical -(CR8R9)-, Z1 is -O-, -NR10-, -CH2-,-(CR11R12)- or -C(=O)- and R1 to R12 are optionally substituted hydrocarbon residues, as precursors for radicals useful in reactions triggered by free radicals, such as polymerization of unsaturated monomers and degradation of polyolefins. Most of the triazenes of formula (I) are novel and claimed, too, as well as the preparation of triazenes of formula (I) and polymerisable compositions comprising them.
    该发明涉及使用式(I)中的三氮烯,其中Q是直接键或二价基团-(CR8R9)-,Z1是-O-,-NR10-,-CH2-,-(CR11R12)-或-C(=O)-,R1至R12是可选择取代的碳氢基团,作为自由基引发的反应中有用的自由基前体,例如不饱和单体的聚合和聚烯烃的降解。大多数式(I)中的三氮烯是新颖的并且被声明为专利,还包括制备式(I)中的三氮烯以及包含它们的可聚合组合物。
  • BLACK DISAZO DYES, THEIR PREPARATION AND USE
    申请人:BAETTIG Kurt
    公开号:US20120090503A1
    公开(公告)日:2012-04-19
    Black disazo dyes of general formula (V) wherein A is a moiety of formula (VI) or of formula (VII) and B is a moiety of formula (VIII) or of formula (IX) and wherein M, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 and R 24 are as defined in the specification, are excellent black dyes for dying and printing cellulose containing materials and textile materials and, in particular, for the preparation of recording liquids for ink jet printing and for writing utensils.
    通式(V)的黑色二氮基染料,其中A是式(VI)或式(VII)的基团,B是式(VIII)或式(IX)的基团,其中M、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12、R13、R14、R15、R16、R17、R18、R19、R20、R21、R22、R23和R24如规范中定义,对于染色和印刷含纤维素材料和纺织品材料,特别是用于制备喷墨打印记录液和书写工具,是极好的黑色染料
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫